Fujian Wanchen Biotechnology Co. Ltd Net Asset Quality Index
Fujian Wanchen Biotechnology Co. Ltd net asset quality index. Fujian Wanchen Biotechnology Co. Ltd (300972) has a Net Asset Quality Index of 31.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥10.76 Billion minus total liabilities of CN¥7.34 Billion yields net assets of CN¥3.42 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 300972 total equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
Net asset quality index of Fujian Wanchen Biotechnology Co. Ltd from 2019 to 2025. This chart shows how Fujian Wanchen Biotechnology Co. Ltd's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the index stands at 31.8%, representing net assets of CN¥3.42 Billion against total assets of CN¥10.76 Billion CNY. Check 300972 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Fujian Wanchen Biotechnology Co. Ltd Net Asset Quality Index by Year (2019–2025)
Fujian Wanchen Biotechnology Co. Ltd net asset quality index by year from 2019 to 2025. The table below presents the year-by-year Net Asset Quality Index for Fujian Wanchen Biotechnology Co. Ltd from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Fujian Wanchen Biotechnology Co. Ltd stock valuation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 25.4% | CN¥2.55 Billion | CN¥10.05 Billion | CN¥7.50 Billion | ▲ +5.2 pp |
| 2024 | 20.1% | CN¥1.46 Billion | CN¥7.25 Billion | CN¥5.79 Billion | ▲ +2.4 pp |
| 2023 | 17.7% | CN¥695.81 Million | CN¥3.93 Billion | CN¥3.23 Billion | ▼ -38.3 pp |
| 2022 | 56.0% | CN¥672.36 Million | CN¥1.20 Billion | CN¥528.79 Million | ▼ -19.6 pp |
| 2021 | 75.6% | CN¥652.71 Million | CN¥863.18 Million | CN¥210.47 Million | ▲ +14.8 pp |
| 2020 | 60.8% | CN¥400.65 Million | CN¥658.59 Million | CN¥257.94 Million | ▲ +8.2 pp |
| 2019 | 52.6% | CN¥344.82 Million | CN¥655.63 Million | CN¥310.81 Million | — |